174 related articles for article (PubMed ID: 35247880)
1. Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer.
Rybicki BA; Sadasivan SM; Chen Y; Loveless I; Gupta NS; Chitale DA; Williamson SR; Rundle AG; Tang DL
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):991-998. PubMed ID: 35247880
[TBL] [Abstract][Full Text] [Related]
2. Obesity is Associated with Shorter Telomere Length in Prostate Stromal Cells in Men with Aggressive Prostate Cancer.
Joshu CE; Heaphy CM; Barber JR; Lu J; Zarinshenas R; Davis C; Han M; Lotan TL; Sfanos KS; De Marzo AM; Meeker AK; Platz EA
Cancer Prev Res (Phila); 2021 Apr; 14(4):463-470. PubMed ID: 33355185
[TBL] [Abstract][Full Text] [Related]
3. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.
Heaphy CM; Gaonkar G; Peskoe SB; Joshu CE; De Marzo AM; Lucia MS; Goodman PJ; Lippman SM; Thompson IM; Platz EA; Meeker AK
Prostate; 2015 Aug; 75(11):1160-6. PubMed ID: 25893825
[TBL] [Abstract][Full Text] [Related]
4. Growth and differentiation factor 15 and NF-κB expression in benign prostatic biopsies and risk of subsequent prostate cancer detection.
Rybicki BA; Sadasivan SM; Chen Y; Kravtsov O; Palangmonthip W; Arora K; Gupta NS; Williamson S; Bobbitt K; Chitale DA; Tang D; Rundle AG; Iczkowski KA
Cancer Med; 2021 May; 10(9):3013-3025. PubMed ID: 33784024
[TBL] [Abstract][Full Text] [Related]
5. Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer.
Julin B; Shui I; Heaphy CM; Joshu CE; Meeker AK; Giovannucci E; De Vivo I; Platz EA
Br J Cancer; 2015 Feb; 112(4):769-76. PubMed ID: 25562437
[TBL] [Abstract][Full Text] [Related]
6. Telomere length as a risk factor for hereditary prostate cancer.
Hurwitz LM; Heaphy CM; Joshu CE; Isaacs WB; Konishi Y; De Marzo AM; Isaacs SD; Wiley KE; Platz EA; Meeker AK
Prostate; 2014 Apr; 74(4):359-64. PubMed ID: 24285042
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells.
Joshu CE; Peskoe SB; Heaphy CM; Kenfield SA; Van Blarigan EL; Mucci LA; Giovannucci EL; Stampfer MJ; Yoon G; Lee TK; Hicks JL; De Marzo AM; Meeker AK; Platz EA
Cancer Prev Res (Phila); 2015 Aug; 8(8):737-42. PubMed ID: 25990087
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.
Xu J; Chang WS; Tsai CW; Bau DT; Xu Y; Davis JW; Thompson TC; Logothetis CJ; Gu J
EBioMedicine; 2020 Feb; 52():102616. PubMed ID: 31981976
[TBL] [Abstract][Full Text] [Related]
9. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer.
Mirabello L; Huang WY; Wong JY; Chatterjee N; Reding D; Crawford ED; De Vivo I; Hayes RB; Savage SA
Aging Cell; 2009 Aug; 8(4):405-13. PubMed ID: 19493248
[TBL] [Abstract][Full Text] [Related]
10. Telomere length and Parkinson's disease in men: a nested case-control study.
Schürks M; Buring J; Dushkes R; Gaziano JM; Zee RY; Kurth T
Eur J Neurol; 2014; 21(1):93-9. PubMed ID: 24010387
[TBL] [Abstract][Full Text] [Related]
11. Telomere length and pancreatic cancer: a case-control study.
Skinner HG; Gangnon RE; Litzelman K; Johnson RA; Chari ST; Petersen GM; Boardman LA
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2095-100. PubMed ID: 23093543
[TBL] [Abstract][Full Text] [Related]
12. The prostate tissue-based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy.
Heaphy CM; Joshu CE; Barber JR; Davis C; Lu J; Zarinshenas R; Giovannucci E; Mucci LA; Stampfer MJ; Han M; De Marzo AM; Lotan TL; Platz EA; Meeker AK
J Pathol Clin Res; 2022 Sep; 8(5):481-491. PubMed ID: 35836303
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.
Heaphy CM; Yoon GS; Peskoe SB; Joshu CE; Lee TK; Giovannucci E; Mucci LA; Kenfield SA; Stampfer MJ; Hicks JL; De Marzo AM; Platz EA; Meeker AK
Cancer Discov; 2013 Oct; 3(10):1130-41. PubMed ID: 23779129
[TBL] [Abstract][Full Text] [Related]
14. Association between leukocyte telomere length and the risk of pancreatic cancer: Findings from a prospective study.
Luu HN; Huang JY; Wang R; Adams-Haduch J; Jin A; Koh WP; Yuan JM
PLoS One; 2019; 14(8):e0221697. PubMed ID: 31465482
[TBL] [Abstract][Full Text] [Related]
15. Telomere length in white blood cell DNA and lung cancer: a pooled analysis of three prospective cohorts.
Seow WJ; Cawthon RM; Purdue MP; Hu W; Gao YT; Huang WY; Weinstein SJ; Ji BT; Virtamo J; Hosgood HD; Bassig BA; Shu XO; Cai Q; Xiang YB; Min S; Chow WH; Berndt SI; Kim C; Lim U; Albanes D; Caporaso NE; Chanock S; Zheng W; Rothman N; Lan Q
Cancer Res; 2014 Aug; 74(15):4090-8. PubMed ID: 24853549
[TBL] [Abstract][Full Text] [Related]
16. Circulating Prostate-Specific Antigen and Telomere Length in a Nationally Representative Sample of Men Without History of Prostate Cancer.
Wulaningsih W; Astuti Y; Matsuguchi T; Anggrandariyanny P; Watkins J;
Prostate; 2017 Jan; 77(1):22-32. PubMed ID: 27566127
[TBL] [Abstract][Full Text] [Related]
17. Association between prediagnostic leukocyte telomere length and breast cancer risk: the Singapore Chinese Health Study.
Samavat H; Xun X; Jin A; Wang R; Koh WP; Yuan JM
Breast Cancer Res; 2019 Apr; 21(1):50. PubMed ID: 30995937
[TBL] [Abstract][Full Text] [Related]
18. Telomere length, cigarette smoking, and bladder cancer risk in men and women.
McGrath M; Wong JY; Michaud D; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):815-9. PubMed ID: 17416776
[TBL] [Abstract][Full Text] [Related]
19. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in benign prostate and subsequent risk for prostate cancer.
Tang D; Kryvenko ON; Wang Y; Trudeau S; Rundle A; Takahashi S; Shirai T; Rybicki BA
Int J Cancer; 2013 Aug; 133(4):961-71. PubMed ID: 23400709
[TBL] [Abstract][Full Text] [Related]
20. Long leukocyte telomere length in prostate cancer patients at diagnosis is associated with poor metastasis-free and cancer-specific survival.
Svenson U; Roos G; Wikström P
Tumour Biol; 2017 Feb; 39(2):1010428317692236. PubMed ID: 28222672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
